Characterizing Pediatric Tuberculosis with and without Human Immunodeficiency Virus Coinfection in Harare, Zimbabwe

Michelle Earley1, Joconiah Chirenda2, Alexandra Highet3

  • 1Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan.

Insights

Pediatric tuberculosis (TB) and HIV coinfection significantly impact children in high-burden areas. Targeted interventions are crucial for reducing child mortality from TB and HIV.

Area of Science:

  • Global Health
  • Pediatric Infectious Diseases
  • Epidemiology

Background:

  • Pediatric tuberculosis (TB) is a major obstacle to reducing global TB mortality, particularly in regions with co-occurring TB and HIV epidemics.
  • Limited epidemiological data exists for pediatric TB in high-burden settings, hindering targeted research and interventions.

Purpose of the Study:

  • To characterize the epidemiology of pediatric TB in Harare, Zimbabwe, a high-burden setting.
  • To identify predictors of HIV coinfection among pediatric TB cases.

Main Methods:

  • Analysis of de-identified data from 1,051 pediatric TB cases (ages 0-14) out of 11,607 total TB cases reported in Harare, Zimbabwe (2011-2012).
  • Utilized Pearson's chi-squared test and multivariate logistic regression to analyze epidemiological characteristics and HIV coinfection predictors.

Main Results:

  • Pediatric TB constituted 9.1% of all reported TB cases; 50% of pediatric cases were under 5 years old.
  • The overall HIV coinfection rate was 58.3%, with higher odds in older children (5-14 years), retreatment cases, and pulmonary TB.
  • Observed distinct gender distribution patterns across different pediatric age groups.

Conclusions:

  • Pediatric TB, exacerbated by HIV coinfection, poses a significant public health challenge in high-burden settings.
  • Findings underscore the urgent necessity for tailored interventions and further research to address pediatric TB and HIV coinfection.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
What are Viruses?00:50

What are Viruses?

Overview
128.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
991
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
630
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266